Healthcare Marketing Blogs

12|13|23

First and Third-Party Cookies – Privacy Implications on Paid Media

In the dynamic realm of digital marketing, leveraging first-party and third-party cookies is akin to navigating uncharted territories. And while these data sources have long been the bedrock of digital strategies, the landscape has drastically shifted with the surge in privacy legislation. In this POV, we outline how valuable data from first-party and third-party cookies […]

12|01|23

Cannes Lions, Ad Forum Spotlight The Chrysalis Initiative & EVERSANA INTOUCH in New Webinar, Article

Our award-winning campaign for The Chrysalis Initiative is showcased in a new article on Ad Forum, and in an upcoming webinar from Cannes Lions, where it won gold this year.

11|20|23

What We’re Watching for 2024 – Top Trends in Market Access

Learn the top trends in market access to watch for in 2024 and how they'll impact your brand's strategy and success in the dynamic pharma landscape.

11|16|23

Reaching New Global ‘Frontiers’ In Life Sciences

EVERSANA and Healthware colleagues reached new global 'Frontiers' together as they co-hosted the 2023 Frontiers Health conference in Rome, Italy. Learn more about the event in this recent blog.

11|09|23

Ten Ways to Think Differently About Small-to-Mid-Sized Pharma Launches

In this POV, we identify practical, exciting ideas that smaller launchers should use to address challenges.

10|25|23

Orchestrating Experiences That Simultaneously Drive Brand Impact and Customer Delight

In this POV, Aaron Uydess, Executive Vice President, Product Strategy and Sales, lays out many of the challenges and solutions facing omnichannel implementation in today’s marketplace. He also introduces EVERSANA ORCHESTRATE™, the industry’s first end-to-end modular omnichannel model that drives patient and provider connectivity across multiverse journeys and transcends the limitations of traditional omnichannel solutions.

10|13|23

How Pharma Companies Can – And Should – Improve Social Determinants of Health

Social determinants of health are the non-medical factors that can drive as much as 80% of health outcomes. In this article, Becca Sturey, Senior Copywriter, EVERSANA INTOUCH Engage, explains more about SDOH, and how pharma companies are helping to improve them.

10|10|23

Move Over, White Whales – Zebras Are Here

Pharma has historically sought to find blockbuster drugs - the extremely popular drugs that elicit comparisons with the elusive white whale - but that has neglected "zebras," the symbol of rare disease. Fortunately, things are changing.

09|14|23

Digital Medicine in Pharma: A Marketers’ Guide for Launch, Promotion and Life Cycle Management

Beyond the pill, there are treatments that pharma marketers are launching, promoting and managing throughout their life cycle. Check out this POV, for a guide on marketing digital medicine in pharma.

08|25|23

What the Success of “Barbie” Means for Women’s Health

In a recent article for PharmaLive.com and Med Ad News, Elizabeth Rooney, Managing Director, Executive Creative Director, EVERSANA INTOUCH urges all healthcare marketers to make the most of "Barbie" grabbing the cultural zeitgeist to make a difference for women's health.

Load More Posts